Publications

Learn more about our science.

April 2025

Preclinical discovery and characterization of EO-1022, a site-specific glycan-conjugated anti-HER3 vcMMAE ADC for treating solid tumors

All
Posters & Oral Presentations
Manuscripts

Track our progress

Check back often for our latest insights, or sign up for our mailing list to receive the have the latest news and publications from Elevation Oncology delivered to your inbox.